Literature DB >> 26576092

Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

René Fahrner1, Felix Dondorf1, Michael Ardelt1, Yves Dittmar1, Utz Settmacher1, Falk Rauchfuß1.   

Abstract

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide. Liver transplantation can be a curative treatment in selected patients. However, there are several factors that influence disease-free survival after transplantation. This review addresses the pre-, intra- and postoperative factors that influence the risk of tumor recurrence after liver transplantation.

Entities:  

Keywords:  Diagnostics; Hepatocellular carcinoma; Liver transplantation; Recurrence; Risk factor; Survival

Mesh：

Substances：

Year:  2015        PMID： 26576092      PMCID： PMC4641125          DOI： 10.3748/wjg.v21.i42.12071

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  170 in total

Review 1.  microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Xiaofei Li; Wenjun Yang; Lianqing Lou; Yongxin Chen; Shuang Wu; Guoqiang Ding
Journal:  Dig Dis Sci       Date:  2014-01-04       Impact factor: 3.199

2.  Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

Authors:  Michał Grąt; Oskar Kornasiewicz; Zbigniew Lewandowski; Wacław Hołówko; Karolina Grąt; Konrad Kobryń; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

3.  Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.

Authors:  Su Yeon Ahn; Jeong Min Lee; Ijin Joo; Eun Sun Lee; Soo Jin Lee; Gi Jeong Cheon; Joon Koo Han; Byung Ihn Choi
Journal:  Abdom Imaging       Date:  2015-04

4.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

5.  Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.

Authors:  H-J Song; J-Y Cheng; S-L Hu; G-Y Zhang; Y Fu; Y-J Zhang
Journal:  Clin Radiol       Date:  2014-11-04       Impact factor: 2.350

Review 6.  What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?

Authors:  Christophe Duvoux; Tetsuya Kiuchi; Bernhard Pestalozzi; Ronald Busuttil; Rebecca Miksad
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

7.  Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.

Authors:  Sami Akbulut; Cuneyt Kayaalp; Mehmet Yilmaz; Volkan Ince; Dincer Ozgor; Koray Karabulut; Cengiz Eris; Huseyin Ilksen Toprak; Cemalettin Aydin; Sezai Yilmaz
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 8.  Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.

Authors:  Matteo Cescon; Alessandro Cucchetti; Matteo Ravaioli; Antonio Daniele Pinna
Journal:  J Hepatol       Date:  2012-10-04       Impact factor: 25.083

Review 9.  Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis.

Authors:  Austin G Acheson; Matthew J Brookes; Donat R Spahn
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

10.  Metabolic profiling of Staphylococcus aureus cultivated under aerobic and anaerobic conditions with (1)H NMR-based nontargeted analysis.

Authors:  Ji-Lu Sun; Shao-Kang Zhang; Jing-Yu Chen; Bei-Zhong Han
Journal:  Can J Microbiol       Date:  2012-05-09       Impact factor: 2.419
View more
  5 in total

1.  Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.

Authors:  E Dudley Colhoun; C Gunnar Forsberg; Kenneth D Chavin; Prabhakar K Baliga; David J Taber
Journal:  Surgery       Date:  2016-10-19       Impact factor: 3.982

2.  A model integrated fibrinogen and D-dimer for prediction of hepatocellular carcinoma recurrence following liver transplantation: a multicentre study.

Authors:  Chao Wang; Zhikun Liu; Jun Chen; Wei Rao; Siyi Dong; Modan Yang; Shusen Zheng; Yunjin Zang; Xiao Xu
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation.

Authors:  Jiliang Feng; Jushan Wu; Ruidong Zhu; Dezhao Feng; Lu Yu; Yan Zhang; Dayu Bu; Chenlei Li; Yuyan Zhou; Lianghao Si; Yuhan Liu; Ziwei Liang; Jianing Xu; Tianjun Wu
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

4.  Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation.

Authors:  Tao Ma; Qing-Shan Li; Yue Wang; Bo Wang; Zheng Wu; Yi Lv; Rong-Qian Wu
Journal:  World J Gastroenterol       Date:  2019-04-21       Impact factor: 5.742

Review 5.  Updates on the Diagnosis and Management of Hepatocellular Carcinoma.

Authors:  Aimun Raees; Muhammad Kamran; Hasan Özkan; Wasim Jafri
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jan-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.